Shots: The approval is based on efficacy and safety data from the P-III LIBERTY 1 & 2 studies assessing Myfembree (relugolix 40 mg, estradiol 1 mg & norethindrone acetate 0.5 […]readmore
Tags : Myovant Sciences
Shots: The P-III HERO study involves assessing of Relugolix (360mg loading dose followed by 120mg, qd) vs leuprolide acetate (3mos. depot injection) in men in ratio 2:1 with androgen-sensitive advanced […]readmore
Shots: The P-III LIBERTY 1 study results involves assessing of relugolix (40mg) + estradiol (1.0mg) & norethindrone acetate (0.5mg)/relugolix (40mg) as monothx. + relugolix combination therapy vs PBO in 388 […]readmore